Blog: The Story Behind the Headlines
Fast updates, deep dives, trial breakdowns, safety analysis, and the questions behind the latest retatrutide headlines.
How Fast Does Retatrutide Work? A Week-by-Week Timeline From the Phase 2 and TRIUMPH Trials
How fast retatrutide works: about 17% weight loss by week 24, 24% by week 48, 28% at week 80 and 30% at two years in trials. Timeline, comparisons and caveats.
How to Get Retatrutide Legally in 2026: Clinical Trials Only, and What to Use Until Approval
The only legal way to get retatrutide in 2026 is a clinical trial. How to find one, the trade-offs, why online vials are not it, the 2027 timeline, options now.
What Is GLP-3 RT? Why "GLP-3" Is a Label for Unapproved Retatrutide
GLP-3 is not a hormone and GLP-3 RT is not a drug: it is a seller name for unapproved retatrutide. What the real trials show, FDA warnings, what to do instead.
How Much Will Retatrutide Cost? What We Know So Far
Retatrutide has no price yet. What Lilly has said, what Zepbound and Wegovy cost in 2026, likely price scenarios, insurance outlook and the launch timeline.
Retatrutide vs Tirzepatide: What the Trials Show So Far
Retatrutide vs tirzepatide (Zepbound, Mounjaro): 28.3% vs 20.9% weight loss in separate trials, side effects, the glucagon difference and TRIUMPH-5.
Retatrutide Dosage in Clinical Trials: What Was Tested and Why
Retatrutide doses in Lilly's trials: 2 mg start, raised every 4 weeks to 4, 9 or 12 mg weekly. Weight loss and side effects by dose. Not a dosing guide.
What Is Retatrutide? The Triple-Hormone Weight-Loss Drug Explained
Retatrutide is Lilly's weekly triple agonist (GIP, GLP-1, glucagon) with up to 28.3% weight loss in trials. What it does, side effects, and FDA status.
Approval Watch: When Will Retatrutide Be FDA Approved?
Retatrutide isn't FDA-approved yet. Lilly plans to file by Q1 2027 after five positive Phase 3 trials. Timeline, what's left, and when it could be available.
Retatrutide vs Ozempic, Wegovy & Zepbound: Which One Actually Wins?
Retatrutide vs semaglutide and tirzepatide: weight loss in trials, receptors, side effects and approval status. Why the 28% vs 15% vs 21% isn't a fair race.
Retatrutide Weight Loss Results: What the Trials Really Show
Retatrutide weight loss in every trial so far: 28.3% at 80 weeks on 12 mg in TRIUMPH-1, 25.0% in the stricter analysis, plus diabetes and heart trials.
Tirzepatide for Cutting: Fat Loss, Muscle Loss and Retatrutide
About 25% of weight lost on tirzepatide was lean mass in SURMOUNT-1. What that means for a cut, what's known about retatrutide, and how to protect muscle.
